As the COVID-19 pandemic continues to adversely affect communities, the Vera and Joseph Dresner Foundation will extend its realigned grantmaking strategy into 2021. Supported programs

This national funding initiative expands the Foundation’s investments in support of cutting-edge MDS research and related programs that will lead to the future standards of

The Vera and Joseph Dresner Foundation Board of Directors is pleased to announce the appointment of Maria Figueroa, MD, as the Chair of the Foundation’s

To better serve communities during the COVID-19 outbreak, the Vera and Joseph Dresner Foundation has realigned its grantmaking strategy for the remainder of 2020. The

In response to the impact of COVID-19, the Vera and Joseph Dresner Foundation has created a fund to assist organizations responding to the emerging critical

This national funding initiative expands the Foundation’s investments in support of cutting-edge MDS research and related programs that will lead to the future standards of

The Vera and Joseph Dresner Foundation is pleased to announce its third annual Myelodysplastic Syndrome (MDS) Research Fund grant recipients. Grants were awarded to The

The Vera and Joseph Dresner Foundation introduces Erin Marie McDonald as the Grant and Program Associate. In this position, Ms. McDonald will support all aspects

This national funding initiative expands the Foundation’s investments in support of cutting-edge MDS research and related programs that will lead to the future standards of

The Dresner Foundation is proud to announce its second annual Myelodysplastic Syndrome (MDS) Research Fund grant recipients. Grants were awarded to H. Lee Moffitt Cancer